GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-R) » Definitions » Forward Dividend Yield %

Mega Lifesciences PCL (BKK:MEGA-R) Forward Dividend Yield % : 5.89% (As of Jul. 18, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Forward Dividend Yield %?

As of today (2025-07-18), the Forward Annual Dividend Yield of Mega Lifesciences PCL is 5.89%.

As of today (2025-07-18), the Trailing Annual Dividend Yield of Mega Lifesciences PCL is 5.89%.

BKK:MEGA-R's Forward Dividend Yield % is ranked better than
93.71% of 493 companies
in the Drug Manufacturers industry
Industry Median: 1.84 vs BKK:MEGA-R: 5.89

Mega Lifesciences PCL's Dividends per Share for the three months ended in Mar. 2025 was ฿0.80.

During the past 3 years, the average Dividends Per Share Growth Rate was 14.70% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 21.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 19.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Mega Lifesciences PCL was 31.40% per year. The lowest was 12.60% per year. And the median was 17.40% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Mega Lifesciences PCL's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Mega Lifesciences PCL's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mega Lifesciences PCL's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mega Lifesciences PCL's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Mega Lifesciences PCL's Forward Dividend Yield % falls into.


;
;

Mega Lifesciences PCL Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Mega Lifesciences PCL Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
THB 0.8000002025-03-072025-03-102025-04-25Cash Dividendsemi-annuallyTHB:THB 1.000000
THB 0.8000002024-08-232024-08-262024-09-11Cash Dividendsemi-annuallyTHB:THB 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Mega Lifesciences PCL's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=1.6/27.08483
=5.91 %

Current Share Price is ฿27.08483.
Mega Lifesciences PCL's Dividends per Share for the forward twelve months is calculated as ฿0.8 * 2 = ฿1.6.

Mega Lifesciences PCL's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=1.6/27.08483
=5.91 %

Current Share Price is ฿27.08483.
Mega Lifesciences PCL's Dividends per Share for the trailing twelve months (TTM) ended in Today is ฿1.6.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mega Lifesciences PCL  (BKK:MEGA-R) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Mega Lifesciences PCL Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mega Lifesciences PCL Business Description

Traded in Other Exchanges
Address
Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260
Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines